While protein binding and ionisation of the drug in serum/plasma are likely to change little in disease, especially in chronic infections, the tissue changes may be greater. That will have a significant effect on the drug concentration at the infection site. The results of the present study enable these scores to be calculated and provide concentrations of AZM in the skin of healthy dogs and dogs with pyoderma.